Adeno-associated virus gene therapy (Applied Genetic technologies)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAdeno-associated virus gene therapy (Applied Genetic technologies)
Drug Alias NamemAAV8-GRK1-PDEbetaAAV5-CBA-XIAP-wPREAAV5-smCBA-PDEbeta
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of Action3',5'-cyclic phosphodiesterase modulatorsInhibitor of apoptosis protein 3 modulators
TargetsInhibitor of apoptosis protein 33',5'-cyclic phosphodiesterase
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBeacon Therapeutics Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeacon Therapeutics Holdings Ltd
Active IndicationsN/A
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A